Cantata Bio

📍 Scotts Valley, United States🗓 Founded 2022👥 30 employees💰 Last funded Jul 2016
Cantata Bio is enabling researchers and clinicians to solve tomorrow’s most challenging scientific problems through novel, multiomic approaches that unlock access to genomic and metagenomic information at unprecedented levels. Combining propriety technologies with platform solutions, services, and cutting-edge bioinformatics and software, our unique approaches are solving complex problems, including chromatin topology analysis, small and large structural variant detection, de novo chromosome assembly, haplotype phasing, metagenomics, and microbiome analysis. Our customers are positively impacting the fields of epigenetics, developmental biology, cancer research, evolutionary biology, infectious disease, and more. Cantata Bio is based in Scotts Valley, California and Cambridge, Massachusetts. For more information on Cantata Bio, its technology, and offerings, visit www.cantatabio.com.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Cantata Bio?
Cantata Bio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Cantata Bio last raise funding?
The most recent investment in Cantata Bio recorded on gritt.io was in July 2016.
When was Cantata Bio founded?
Cantata Bio was founded in 2022.
What industry is Cantata Bio in?
Cantata Bio operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Cantata Bio based?
Cantata Bio is headquartered in Scotts Valley, United States.